Bacterial sepsis: Challenges of diagnosis and treatment in a teaching hospital Southwest of Iran

Jundishapur Journal of Microbiology

Volumn 7, Issue 3, 2014, Pages

  Alavi, Seyed Mohammad ^a   Sharifi, Mehrdad ^a   Eghtesad, Mehdi ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bacterial Sepsis; Diagnosis; Therapeutics

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG USE; ESCHERICHIA COLI; HOSPITAL DEPARTMENT; HUMAN; INTENSIVE CARE UNIT; IRAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; PSEUDOSEPSIS; RETROSPECTIVE STUDY; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; TEACHING HOSPITAL;

EID: 84896457348     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.9082     Document Type: Article

References (22)

1. Munford RS, Suffredini A. Sepsis, severe sepsis and septic shock. In: Mandell GL, Bennett JE, Dolin R editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 7 ed: Churchill Livingstone/Elsevier; 2010. p. 987-1011.
2. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008; 34(1): 17-60.
3. Hirasawa H, Oda S, Nakamura M. Blood glucose control in patients with severe sepsis and septic shock. World J Gastroenterol. 2009; 15(33): 4132-6.
4. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31(4): 1250-6.
5. Cunha BA. Fever in the critical care unit. Crit Care Clinics. 1998; 14(1): 1-14.
6. Russell JA. Management of sepsis. N Engl J Med. 2006; 355(16): 1699-713.
7. The World Bank. World Bank list of economies (July 2009). 2010.
8. Suarez C, Pena C, Tubau F, Gavalda L, Manzur A, Dominguez MA, et al. Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections. J Infect. 2009; 58(4): 285-90.
9. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101(6): 1644-55.
10. Soong J, Soni N. Sepsis: recognition and treatment. Clin Med. 2012; 12(3): 276-80.
11. Cusini A, Rampini SK, Bansal V, Ledergerber B, Kuster SP, Ruef C, et al. Different patterns of inappropriate antimicrobial use in surgical and medical units at a tertiary care hospital in Switzerland: a prevalence survey. PLoS One. 2010; 5(11).
12. Boroumand MA, Esfahanifard P, Saadat S, Sheihkvatan M, Hekmatyazdi S, Saremi M, et al. A report of Pseudomonas aeruginosa antibiotic resistance from a multicenter study in Iran. Indian J Med Microbiol. 2007; 25(4): 435-6.
13. Khorshidi A, Sharif A. Imipenem Resistance among Gram-Negative and Gram-Positive Bacteria in Hospitalized Patients. Iran J Public Health. 2010; 39(2): 110-3.
14. Shahcheraghi F, Nikbin Vs, shorej F. [PCR detection of PER & amp; VEB & amp; SHV and TEM β-lactamases in multidrug resistant P. aeruginoasa isolated from wound infections in two hospitals of Tehran]. Iran J Med Microbiol. 2008; 1(4): 21-7.
15. Shahcheraghi F, Noveiri H, Nasiri S. Detection of bla TEM and bla SHVgenes among clinical isolates of E. coli from Tehran hospitals. Iran J Med Microbiol. 2007; 1(3): 1-8.
16. Barantsevich E, Barantsevich N, Rybkova N, Churkina I, Pestova N, Karpenko M. Etiological agents of bacterial sepsis in a newly constructed medical center in Saint Petersburg, Russia. Crit Care. 2011; 15(Suppl 3): P45.
17. Carvalho PR, Trotta Ede A. [Advances in sepsis diagnosis and treatment]. J Pediatr (Rio J). 2003; 79 Suppl 2: S195-204.
18. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003; 115(7): 529-35.
19. Mojtahedzadeh M, Panahi Y, Fazeli MR, Najafi A, Pazouki M, Navehsi BM, et al. Intensive care unit-acquired urinary tract infections in patients admitted with sepsis: etiology, risk factors, and patterns of antimicrobial resistance. Int J Infect Dis. 2008; 12(3): 312-8.
20. Lever A, Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ. 2007; 335(7625): 879-83.
21. McGowan JE, Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis. 1983; 5(6): 1033-48.
22. Ghotaslou R, Ghorashi Z, Nahaei MR. Klebsiella pneumoniae in neonatal sepsis: a 3-year-study in the pediatric hospital of Tabriz, Iran. Jpn J Infect Dis. 2007; 60(2-3): 126-8.